Tomorrow’s the day! Catch Senior Security Consultant @InfoSteph1 moderating “Zero Day, Zero Limits: Women Leading Cyber” at @ThreeRiversISec in Pittsburgh at 1:00PM. Add it to your schedule! https://t.co/zkXsjs9MuG
Last @ISC2 Cleveland Chapter meeting of the year—and what a topic to end it! Join us next Tuesday from 5:30-8:00PM at TrustedSec HQ for Matt Lee’s presentation, “Giving Swords to Our AI Overlords.” Register now! https://t.co/2VNylHkjbl
GPT-Rosalind surfaced a new lead for drug discovery: could restoring cholesterol transport protect neurons from degeneration?
DCTN1 is a gene linked to Perry syndrome, a rare neurodegenerative disorder. In mouse-brain data, disrupting it increased expression of genes involved in making cholesterol. GPT-Rosalind suggested a possible explanation: cholesterol may not be reaching where neurons need it.
That gives scientists a specific mechanism to test and, if confirmed, a direction for developing new treatments for neurodegenerative disorders.
With @perturbai_tx and @scrippsresearch, a team of thousands of GPT-Rosalind agents worked in parallel, connecting gene-expression results from millions of mouse brain cells with scientific literature in just 32 minutes. We’re now expanding this collaboration to identify new drug targets.
https://t.co/oHdF3ELsMj
Two critical PHP vulnerabilities (CVSS 9.2) were disclosed today, allowing unauthenticated RCE on default configurations.
To help everyone patch fast we are making images for PHP 8.2, 8.3, 8.4, and 8.5 free for anyone to use. You can access them here: https://t.co/MH7tCEF7ZE
Coordinated disclosure is hard, we appreciated everyone's help as we worked through this over the last several days.
BREAKING: The FDA just granted accelerated approval to the first immunotherapy for a leading cause of cancer death in U.S. men under 50. This therapy allows certain patients to skip radiation, chemo, and surgery altogether.
Came into the gym and found that my son was using barbell clamps/collars on the smith machine.
Def going to have to talk to this boy, can't have that on the smith.